Noventra Pharma Tesamorelin (10mg Multi-Dose Prefilled Pen)

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), supplied in a pre-reconstituted multi-dose pen format for controlled dispensing. It is investigated for its role in stimulating endogenous growth hormone release via pituitary signalling pathways.

Tesamorelin has been studied in clinical and experimental contexts for its interaction with growth hormone and insulin-like growth factor-1 (IGF-1) pathways, particularly in relation to metabolic and endocrine processes.

Key Features:

• 10mg tesamorelin per multi-dose prefilled pen

• GHRH analogue involved in endogenous growth hormone signalling

• Prefilled pen format for controlled and consistent application

• Investigated for interaction with GH and IGF-1 regulatory pathways

• Studied in relation to metabolic and endocrine processes

• Associated in research with adipose tissue and metabolic signalling pathways

Suggested Use:
For use under the guidance of a qualified professional. Protocols vary depending on application and individual requirements.

Storage:

• Store at 2–8°C at all times (refrigerated)

• Do not freeze

• Protect from light

• Avoid repeated temperature fluctuations

• Use within a limited timeframe once in use (based on formulation stability)

Important Information:
Tesamorelin has been studied in clinical settings for specific indications; however, this product should be used within appropriate professional and regulatory frameworks. Not recommended for individuals under 18, pregnant or breastfeeding individuals, or those with certain medical conditions. Ensure compliance with applicable regulations prior to use.